课题基金 / 基金详情

Development of New Drugs that Protect Gastrointestinal Tract from Radiation

Development of New Drugs that Protect Gastrointestinal Tract from Radiation
开发保护胃肠道免受辐射的新药
批准号:
7472938
负责人:
ALEXEY G. RYAZANOV
金额:
$75.0万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2011-02-28

项目摘要

项目成果

ALEXEY G. RYAZANOV的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We have recently discovered a novel intracellular signal transduction pathway involved in the regulation of radiation sensitivity in mammals. This pathway is mediated by the elongation factor 2 kinase (eEF2K), a key regulator of global protein synthesis. We found that inactivation of this pathway in mice can confer resistance to the lethal effects of gamma radiation and protects mice from hair graying caused by radiation. We investigated the role of eEF2 kinase in radiation sensitivity of gastrointestinal tract and we found that inactivation of eEF2 kinase protects cells in the intestine from the radiation-induced cell death. The goal of this proposal is to further characterize this novel signal transduction pathway and to develop approaches that can be used to protect tissues particularly of gastrointestinal tract from radiation damage in humans exposed to terrorist or accidental radiological or nuclear attack. There are the following specific aims in this proposal. 1. To characterize a novel signal transduction pathway involving eEF2 kinase that modulates apoptosis and radiation sensitivity. 2. To identify specific inhibitors of eEF2 kinase and to develop lead compounds that can be used to develop drugs that protect gastrointestinal tract from radiation damage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Use of EF2K Inhibitors to Reduce Toxicity to Normal Tissues in Chemotherapy
  • 批准号:
    8782369
  • 项目类别:
  • 资助金额:
    $22.2万
  • 财政年份:
    2014
  • 负责人:
    ALEXEY G. RYAZANOV
  • 依托单位:
Investigation of synergism between mTOR and eEF2 kinase pathways
Investigation of synergism between mTOR and eEF2 kinase pathways
Investigation of synergism between mTOR and eEF2 kinase pathways
国内基金
海外基金
炎性反应中巨噬细胞激活诱导死亡(activation-induced cell death,AICD)的机理研究
  • 批准号:
    30330260
  • 项目类别:
    重点项目
  • 资助金额:
    105.0万元
  • 批准年份:
    2003
  • 负责人:
    顾军
  • 依托单位: